1887

Abstract

The activation of NF-B has long been considered a positive factor for human cytomegalovirus (HCMV) replication. The HCMV immediate-early promoter, the initial transcriptional element in the HCMV replication cycle, is activated by the transcription factor NF-B, and several HCMV gene products have been demonstrated to activate this transcription factor. However, the role of NF-B in the full replication cycle of the virus has not been carefully examined. A series of experiments that demonstrate an important inhibitory role of NF-B for HCMV replication in fibroblasts is presented here. Using both genetic and pharmaceutical methods, it was shown that blocking NF-B activation in cell culture does not inhibit HCMV replication, but rather leads to a modest increase in replication. Two cytokines inhibitory for HCMV, tumour necrosis factor- and interferon-, no longer inhibit HCMV when NF-B activation is blocked. Furthermore, forced expression of the NF-B activating IB kinase (IKK), but not a kinase inactive mutant, also inhibits HCMV replication. In addition, it was shown that NF-B signalling is essential for the production of an anti-viral factor in the supernatant of HCMV-infected fibroblasts, and identified interferon- as this factor. Thus, the role of NF-B in fibroblasts is to activate a host defence against HCMV.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.80458-0
2005-02-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/86/2/vir860285.html?itemId=/content/journal/jgv/10.1099/vir.0.80458-0&mimeType=html&fmt=ahah

References

  1. Almawi W. Y., Melemedjian O. K. 2002; Negative regulation of NF- κ B activation and function by glucocorticoids. J Mol Endocrinol 28:69–78 [CrossRef]
    [Google Scholar]
  2. Benedict C. A., Banks T. A., Senderowicz L., Ko M., Britt W. J., Angulo A., Ghazal P., Ware C. F. 2001; Lymphotoxins and cytomegalovirus cooperatively induce interferon- β , establishing host-virus détente. Immunity 15:617–626 [CrossRef]
    [Google Scholar]
  3. Benedict C. A., Angulo A., Patterson G., Ha S., Huang H., Messerle M., Ware C. F., Ghazal P. 2004; Neutrality of the canonical NF- κ B-dependent pathway for human and murine cytomegalovirus transcription and replication in vitro. J Virol 78:741–750 [CrossRef]
    [Google Scholar]
  4. Bodaghi B., Goureau O., Zipeto D., Laurent L., Virelizier J. L., Michelson S. 1999; Role of IFN- γ -induced indoleamine 2,3 dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells. J Immunol 162:957–964
    [Google Scholar]
  5. Boyle K. A., Pietropaolo R. L., Compton T. 1999; Engagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathway. Mol Cell Biol 19:3607–3613
    [Google Scholar]
  6. Brown K., Gerstberger S., Carlson L., Franzoso G., Siebenlist U. 1995; Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267:1485–1488 [CrossRef]
    [Google Scholar]
  7. Browne E. P., Shenk T. 2003; Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells. Proc Natl Acad Sci U S A 100:11439–11444 [CrossRef]
    [Google Scholar]
  8. Caposio P., Dreano M., Garotta G., Gribaudo G., Landolfo S. 2004; Human cytomegalovirus stimulates cellular IKK2 activity and requires the enzyme for productive replication. J Virol 78:3190–3195 [CrossRef]
    [Google Scholar]
  9. Carlquist J. F., Edelman L., Bennion D. W., Anderson J. L. 1999; Cytomegalovirus induction of interleukin-6 in lung fibroblasts occurs independently of active infection and involves a G protein and the transcription factor, NF- κ B. J Infect Dis 179:1094–1100 [CrossRef]
    [Google Scholar]
  10. Casarosa P., Bakker R. A., Verzijl D., Navis M., Timmerman H., Leurs R., Smit M. J. 2001; Constitutive signaling of the human cytomegalovirus-encoded chemokine receptor US28. J Biol Chem 276:1133–1137 [CrossRef]
    [Google Scholar]
  11. Chartier C., Degryse E., Gantzer M., Dieterle A., Pavirani A., Mehtali M. 1996; Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli . J Virol 70:4805–4810
    [Google Scholar]
  12. Chiocca S., Baker A., Cotten M. 1997; Identification of a novel anti-apoptotic protein, GAM-1, encoded by the CELO adenovirus. J Virol 71:3168–3177
    [Google Scholar]
  13. Compton T., Kurt-Jones E. A., Boehme K. W., Belko J., Latz E., Golenbock D. T., Finberg R. W. 2003; Human cytomegalovirus activates inflammatory cytokine responses via CD14 and toll-like receptor 2. J Virol 77:4588–4596 [CrossRef]
    [Google Scholar]
  14. Cotten M., Baker A., Birnstiel M. L., Zatloukal K., Wagner E. 1996; Adenovirus polylysine DNA conjugates. In Current Protocols in Human Genetics pp. 12.3.1–12.3.33 Edited by Dracopoli N. C., Haines J. L., Korf B. R., Moir D. T., Morton C. C., Seidman C. E., Seidman J. G., Smith D. R. New York: Wiley;
    [Google Scholar]
  15. Eickhoff J. E., Hanke M., Stein-Gerlach M. 8 other authors 2004; RICK activates an NF- κ B dependent anti-HCMV response. J Biol Chem 279:9642–9652 [CrossRef]
    [Google Scholar]
  16. Ghosh S., Karin M. 2002; Missing pieces in the NF- κ B puzzle. Cell 109:S81–96 [CrossRef]
    [Google Scholar]
  17. Graham F. L., Smiley J., Russell W. C., Nairn R. 1977; Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59–74 [CrossRef]
    [Google Scholar]
  18. Hoffmann A., Levchenko A., Scott M. L., Baltimore D. 2002; The I κ B-NF- κ B signaling module: temporal control and selective gene activation. Science 298:1241–1245 [CrossRef]
    [Google Scholar]
  19. Hoffmann A., Leung T. H., Baltimore D. 2003; Genetic analysis of NF- κ B/Rel transcription factors defines functional specificities. EMBO J 22:5530–5539 [CrossRef]
    [Google Scholar]
  20. Ito M., O'Malley J. A. 1987; Antiviral effects of recombinant human tumor necrosis factor. Lymphokine Res 6:309–318
    [Google Scholar]
  21. Jiang H. Y., Petrovas C., Sonenshein G. E. 2002; RelB-p50 NF- κ B complexes are selectively induced by cytomegalovirus immediate-early protein 1: differential regulation of Bcl-xL promoter activity by NF- κ B family members. J Virol 76:5737–5747 [CrossRef]
    [Google Scholar]
  22. Jordan M. C., Shanley J. D., Stevens J. G. 1977; Immunosuppression reactivates and disseminates latent murine cytomegalovirus. J Gen Virol 37:419–423 [CrossRef]
    [Google Scholar]
  23. Koment R. W. 1985; Lytic cytomegalovirus replication and the hormones of human pregnancy. J Med Virol 15:149–156 [CrossRef]
    [Google Scholar]
  24. Koment R. W. 1989; Restriction to human cytomegalovirus replication in vitro removed by physiological levels of cortisol. J Med Virol 27:44–47 [CrossRef]
    [Google Scholar]
  25. Kowalik T. F., Wing B., Haskill J. S., Azizkhan J. C., Baldwin A. S. Jr, Huang E. S. 1993; Multiple mechanisms are implicated in the regulation of NF- κ B activity during human cytomegalovirus infection. Proc Natl Acad Sci U S A 90:1107–1111 [CrossRef]
    [Google Scholar]
  26. Lang V., Janzen J., Fischer G. Z. 7 other authors 2003; β TrCP-mediated proteolysis of NF- κ B1 p105 requires phosphorylation of p105 serines 927 and 932. Mol Cell Biol 23:402–413 [CrossRef]
    [Google Scholar]
  27. Lathey J. L., Spector S. A. 1991; Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages. J Virol 65:6371–6375
    [Google Scholar]
  28. Lemay P., Boudin M., Milleville M., Boulanger P. 1980; Human adenovirus type 2 protein IIIa. I. Purification and characterization. Virology 101:131–143 [CrossRef]
    [Google Scholar]
  29. Lenardo M. J., Fan C. M., Maniatis T., Baltimore D. 1989; The involvement of NF- κ B in β -interferon gene regulation reveals its role as widely inducible mediator of signal transduction. Cell 57:287–294 [CrossRef]
    [Google Scholar]
  30. Manor E., Sarov I. 1988; Inhibition of CMV replication in human fibroblasts by human monocyte-derived macrophages: implication for CMV persistent infection. Microb Pathog 5:97–107 [CrossRef]
    [Google Scholar]
  31. Marschall M., Freitag M., Weiler S., Sorg G., Stamminger T. 2000; Recombinant green fluorescent protein-expressing human cytomegalovirus as a tool for screening antiviral agents. Antimicrob Agents Chemother 44:1588–1597 [CrossRef]
    [Google Scholar]
  32. McKay L. I., Cidlowski J. A. 1999; Molecular control of immune/inflammatory responses: interactions between nuclear factor- κ B and steroid receptor-signaling pathways. Endocr Rev 20:435–459
    [Google Scholar]
  33. Michou A.-I., Lehrmann H., Saltik M., Cotten M. 1999; Mutational analysis of the avian adenovirus CELO, which provides a basis for gene delivery vectors. J Virol 73:1399–1410
    [Google Scholar]
  34. Paya C. V., Kenmotsu N., Schoon R. A., Leibson P. J. 1988; Tumor necrosis factor and lymphotoxin secretion by human natural killer cells leads to antiviral cytotoxicity. J Immunol 141:1989–1995
    [Google Scholar]
  35. Pollock J. L., Presti R. M., Paetzold S., Virgin H. W. IV 1997; Latent murine cytomegalovirus infection in macrophages. Virology 227:168–179 [CrossRef]
    [Google Scholar]
  36. Prosch S., Staak K., Stein J., Liebenthal C., Stamminger T., Volk H. D., Kruger D. H. 1995; Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNF α is mediated via induction of NF- κ B. Virology 208:197–206 [CrossRef]
    [Google Scholar]
  37. Russell W. C. 2000; Update on adenovirus and its vectors. J Gen Virol 81:2573–2604
    [Google Scholar]
  38. Sambucetti L. C., Cherrington J. M., Wilkinson G. W., Mocarski E. S. 1989; NF- κ B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J 8:4251–4258
    [Google Scholar]
  39. Sedmak D. D., Chaiwiriyakul S., Knight D. A., Waldmann W. J. 1995; The role of interferon beta in human cytomegalovirus-mediated inhibition of HLA DR induction on endothelial cells. Arch Virol 140:111–126 [CrossRef]
    [Google Scholar]
  40. Soderberg-Naucler C., Fish K. N., Nelson J. A. 1997; Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91:119–126 [CrossRef]
    [Google Scholar]
  41. Tanaka J., Ogura T., Kamiya S., Sato H., Yoshie T., Ogura H., Hatano M. 1984; Enhanced replication of human cytomegalovirus in human fibroblasts treated with dexamethasone. J Gen Virol 65:1759–1767 [CrossRef]
    [Google Scholar]
  42. Torigoe S., Campbell D. E., Torigoe F., Michelson S., Starr S. E. 1993; Cytofluorographic analysis of effects of interferons on expression of human cytomegalovirus proteins. J Virol Methods 45:219–228 [CrossRef]
    [Google Scholar]
  43. Traenckner E. B., Pahl H. L., Henkel T., Schmidt K. N., Wilk S., Baeuerle P. A. 1995; Phosphorylation of human I κ B- α on serines 32 and 36 controls I κ B- α proteolysis and NF- κ B activation in response to diverse stimuli. EMBO J 14:2876–2883
    [Google Scholar]
  44. Velasco N., Catto G. R., Edward N., Engeset J., Moffat M. A. 1984; The effect of the dosage of steroids on the incidence of cytomegalovirus infections in renal transplant recipients. J Infect 9:69–78 [CrossRef]
    [Google Scholar]
  45. Waldhoer M., Kledal T. N., Farrell H., Schwartz T. W. 2002; Murine cytomegalovirus (CMV) M33 and human CMV US28 receptors exhibit similar constitutive signaling activities. J Virol 76:8161–8168 [CrossRef]
    [Google Scholar]
  46. Woronicz J. D., Gao X., Cao Z., Rothe M., Goeddel D. V. 1997; I κ B kinase- β : NF- κ B activation and complex formation with I κ B kinase- α and NIK. Science 278:866–869 [CrossRef]
    [Google Scholar]
  47. Yamamoto N., Shimokata K., Maeno K., Nishiyama Y. 1987; Effect of recombinant human interferon gamma against human cytomegalovirus. Arch Virol 94:323–329 [CrossRef]
    [Google Scholar]
  48. Yurochko A. D., Kowalik T. F., Huong S. M., Huang E. S. 1995; Human cytomegalovirus upregulates NF- κ B activity by transactivating the NF- κ B p105/p50 and p65 promoters. J Virol 69:5391–5400
    [Google Scholar]
  49. Yurochko A. D., Hwang E. S., Rasmussen L., Keay S., Pereira L., Huang E. S. 1997a; The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF- κ B during infection. J Virol 71:5051–5059
    [Google Scholar]
  50. Yurochko A. D., Mayo M. W., Poma E. E., Baldwin A. S. Jr, Huang E. S. 1997b; Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF- κ B promoters. J Virol 71:4638–4648
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.80458-0
Loading
/content/journal/jgv/10.1099/vir.0.80458-0
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error